Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe

References

• Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911;2:814-17
   Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:1572-3
   Google Scholar
• Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen-specific immunotherapy. Allergy 2006;61(Suppl. 82):1-20
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl. 86):8-160
   PubMed Web of Science ®Google Scholar
• Secrist H, Chelen CJ, Wen Y, et al. Allergen immunotherapy decreases interleukin 4 production in CD4 + T cells from allergic individuals. J Exp Med 1993;178:2123-30
   PubMed Web of Science ®Google Scholar
• Francis JN, James LK, Paraskevopoulos G, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008;121:1120-5
   PubMed Web of Science ®Google Scholar
• Wilcock LK, Francis JN, Durham SR. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy. Immunol Allergy Clin North Am 2006;26:333-ix
   PubMed Web of Science ®Google Scholar
• Bousquet J. Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med 2001;164:2139-40
   PubMed Web of Science ®Google Scholar
• Cox L, Li JT, Nelson HS, et al. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(3 Suppl.):S25-S85
   PubMed Web of Science ®Google Scholar
• Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl. 1):1-40
   Web of Science ®Google Scholar
• van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-34
   PubMed Web of Science ®Google Scholar
• Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl.):S1-84
   PubMed Web of Science ®Google Scholar
• Bachert C, van CP. The WHO ARIA (allergic rhinitis and its impact on asthma) initiative. Chem Immunol Allergy 2003;82:119-26
   PubMedGoogle Scholar
• Law AW, Reed SD, Sundy JS, et al. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 2003;111:296-300
   PubMed Web of Science ®Google Scholar
• Donahue JG, Greineder DK, Connor-Lacke L, et al. Utilization and cost of immunotherapy for allergic asthma and rhinitis. Ann Allergy Asthma Immunol 1999;82:339-47
   PubMed Web of Science ®Google Scholar
• Schramm B, Ehlken B, Smala A, et al. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003;21:116-22
   PubMed Web of Science ®Google Scholar
• Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl. 1):1-40
   Google Scholar
• ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-32
   PubMed Web of Science ®Google Scholar
• Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-64
   PubMed Web of Science ®Google Scholar
• Gupta R, Sheikh A, Strachan DP, et al. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520-6
   PubMed Web of Science ®Google Scholar
• Jarvis D, Burney P. ABC of allergies. The epidemiology of allergic disease. BMJ 1998;316:607-10
   PubMed Web of Science ®Google Scholar
• Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992;304:873-5
   PubMed Web of Science ®Google Scholar
• Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(1 Suppl.):S2-S8
   PubMed Web of Science ®Google Scholar
• Mygind N, Dahl R. Epidemiology of allergic rhinitis. Pediatr Allergy Immunol;7(9 Suppl.):57-62
   PubMedGoogle Scholar
• Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007;2126:441-52
   Google Scholar
• Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-25
   PubMed Web of Science ®Google Scholar
• Derebery MJ, Berliner KI. Allergy and health-related quality of life. Otolaryngol Head Neck Surg 2000;123:393-9
   PubMed Web of Science ®Google Scholar
• Blaiss MS. Important aspects in management of allergic rhinitis: compliance, cost, and quality of life. Allergy Asthma Proc 2003;24:231-8
   PubMed Web of Science ®Google Scholar
• Powell RJ, Frew AJ, Corrigan CJ, et al. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis. Allergy 2007;62:1335-8
   PubMed Web of Science ®Google Scholar
• Williams A, Henzgen M, Rajakulasingam K. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis. Eur Ann Allergy Clin Immunol 2007;39:123-6
   PubMedGoogle Scholar
• Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317-24
   PubMed Web of Science ®Google Scholar
• Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. EMEA CHMP, 2008. Available at: http://www.emea.europa.eu/pdfs/human/ewp/1850406enfin.pdf [Last accessed 14 July 2009]
   Google Scholar
• Corrigan CJ, Kettner J, Doemer C, et al. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 2005;60:801-7
   PubMed Web of Science ®Google Scholar
• Drachenberg KJ, Wheeler AW, Stuebner P, et al. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001;56:498-505
   PubMed Web of Science ®Google Scholar
• Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007(1):CD001936
   PubMed Web of Science ®Google Scholar
• Giovannini M, Braccioni F, Sella G, et al. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study. Eur Ann Allergy Clin Immunol 2005;37:69-71
   PubMedGoogle Scholar
• Dolz I, Martinez-Cocera C, Bartolome JM, et al. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996;51:489-500
   PubMed Web of Science ®Google Scholar
• Ferrer M, Burches E, Pelaez A, et al. Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance. J Investig Allergol Clin Immunol 2005;15:283-92
   PubMed Web of Science ®Google Scholar
• Frew AJ, Powell RJ, Corrigan CJ, et al. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:319-25
   PubMed Web of Science ®Google Scholar
• Jutel M, Jaeger L, Suck R, et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-13
   PubMed Web of Science ®Google Scholar
• Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001;107:87-93
   PubMed Web of Science ®Google Scholar
• Ameal A, Vega-Chicote JM, Fernandez S, et al. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005;60:1178-83
   PubMed Web of Science ®Google Scholar
• Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461-72
   PubMed Web of Science ®Google Scholar
• Luigi A, Senna G, Mezzelani P, et al. Safety of specific immunotherapy: a retrospective study. J Investig Allergol Clin Immunol 1994;4:250-4
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001. J Allergy Clin Immunol 2004;113:1129-36
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van CP, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl.):S147-S334
   PubMed Web of Science ®Google Scholar
• Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518
   PubMed Web of Science ®Google Scholar
• Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis. Prim Care Respir J 2006;15:58-70
   PubMedGoogle Scholar
• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38:19-42
   PubMed Web of Science ®Google Scholar
• Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl. 1):1-40
   Google Scholar
• Bonini S, Ansotegui IJ, Durham S, et al. Allergy and clinical immunology services in Europe. Allergy 2006;61:1191-6
   PubMed Web of Science ®Google Scholar
• Mari A, Scala E. Allergenic extracts for specific immunotherapy: to mix or not to mix? Int Arch Allergy Immunol 2006;141:57-60
   PubMed Web of Science ®Google Scholar
• Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009;103:451-60
   PubMed Web of Science ®Google Scholar
• Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-41
   PubMed Web of Science ®Google Scholar
• Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997;336:324-31
   PubMed Web of Science ®Google Scholar
• Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003;92:131-40
   Google Scholar
• Wilson DR, Nouri-Aria KT, Walker SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001;107:971-6
   PubMed Web of Science ®Google Scholar
• Till SJ, Francis JN, Nouri-Aria K, et al. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004;113:1025-34
   PubMed Web of Science ®Google Scholar
• Sehra S, Pynaert G, Tournoy K, et al. Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on FcγR and IFN-γ. J Immunol 2003;171:2080-9
   PubMed Web of Science ®Google Scholar
• Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005;353:1934-44
   PubMed Web of Science ®Google Scholar
• Wheeler AW, Woroniecki SR. Allergy vaccines – new approaches to an old concept. Expert Opin Biol Ther 2004;4:1473-81
   PubMed Web of Science ®Google Scholar
• Patel P, Salapatek AM. Pollinex Quattro: a novel and well-tolerated, ultra short-course allergy vaccine. Expert Rev Vaccines 2006;5:617-29
   PubMed Web of Science ®Google Scholar
• Kaiser HB, Keith PK, Casale TB, et al. Significant reduction in combined sympton and medication score compared with placebo with a ragweed uSCIT formulation for seasonal pollen allergy. J Allergy Clin Immunol 2009;123:731
   Web of Science ®Google Scholar
• Frew AJ, DuBuske LM, Amersdorffer J, et al. Significant benefit in combined symptom and medication scores for ultra short course subcutaneous immunotherapy compared with placebo in patients with grass pollen allergic rhinoconjunctivitis. Allergy 2009;64:s90
   Web of Science ®Google Scholar
• Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 2007;119:906-9
   PubMed Web of Science ®Google Scholar
• Kahlert H, Suck R, Weber B, et al. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Int Arch Allergy Immunol 2008;145:93-206
   Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ, et al. World Health Organization position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:933-44
   PubMedGoogle Scholar
• Wilson DR, Torres L, Durham SR. Sublingual immunotherapy for allergic rhinitis. Allergy 2005;60:3-8
   Web of Science ®Google Scholar
• Penagos M, Complatati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2006;97:141-8
   PubMed Web of Science ®Google Scholar
• Calderon MA, Penagos M, Durham SR. Sublingual immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin Allergy Immunol 2008;21:359-75
   PubMedGoogle Scholar
• Cox LS, Linnemann DL, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021-35
   PubMed Web of Science ®Google Scholar
• Allergenics. FDA, 2008. Available at: http://www.fda.gov/cber/allergenics.htm [Last accessed 16 October 2008]
   Google Scholar
• Larenas-Linnemann D, Cox LS. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008;100:137-45
   PubMed Web of Science ®Google Scholar
• Chapman MD, Ferreira F, Villalba M, et al. The European Union CREATE Project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol 2008;122:882-9
   PubMed Web of Science ®Google Scholar
• Wang DY, Chan A, Smith JD. Management of allergic rhinitis: a common part of practice in primary care clinics. Allergy 2004;59:315-19
   PubMed Web of Science ®Google Scholar
• Derebery JM. Satisfaction level with current treatments for allergic rhinitis. 2006. Available at: http://www.medscape.com/viewarticle/549530 [Last accessed 8 July 2008]
   Google Scholar
• White P, Smith H, Baker N, et al. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 1998;28:266-70
   PubMed Web of Science ®Google Scholar
• Dhanasekar G, Izzat AB, D’Souza AR. Immunotherapy for allergic rhinitis – a United Kingdom survey and short review. J Laryngol Otol 2005;119:799-805
   PubMed Web of Science ®Google Scholar
• Lane A, Pine H, Pillsbury III H. Allergy testing and immunotherapy in an academic otolaryngology practice: a 20-year review. Otolaryngol Head Neck Surg 2001;124:9-15
   PubMed Web of Science ®Google Scholar
• Holgate ST, Ewan P. Allergy: the unmet need. A report of the Royal College of Physicians on the provision of allergy services in the UK. Available at: www.bsaci.org [Last accessed 7 March 2010]
   Google Scholar
• Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-7
   PubMed Web of Science ®Google Scholar
• Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-2
   PubMedGoogle Scholar
• Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008;121:227-322
   PubMed Web of Science ®Google Scholar
• Bousquet J, Reid J, van WC, et al. Allergic rhinitis management pocket reference 2008. Allergy 2008;63:990-6
   PubMed Web of Science ®Google Scholar
• Balda BR, Wolf H, Baumgarten C, et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (SIT) with seven preseasonal injections of molecular standardized allergens. Allergy 1998;53:740–8
   PubMed Web of Science ®Google Scholar
• Bodtger U, Poulsen LK, Jacobi HH, et al. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002;57:297–305
   PubMed Web of Science ®Google Scholar
• Bousquet J, Hejjaoui A, Soussana M, et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunology 1990;85:490–7
   PubMed Web of Science ®Google Scholar
• Brewczynski PZ, Kroon AM. Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study [Wirksamkeit und vertraglichkeit einer immuntherapie mit modifizierten graserpollenallergenen]. Allergologie 1999;22:411–20
   Google Scholar
• Meriney DK, Kothari H, Chinoy P, et al. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Ann Allergy 1986;56:34–8
   PubMedGoogle Scholar
• Ortolani C, Pastorello E, Moss RB, et al. Grass pollen immunotherapy: a single year doubleblind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunology 1984;73:283–90
   PubMed Web of Science ®Google Scholar
• Ortolani C, Pastorello EA, Incorvaia C, et al. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy 1994;49:13–21
   PubMed Web of Science ®Google Scholar
• Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Brit Med J 1991;302:265–9
   PubMed Web of Science ®Google Scholar
• Zenner HP, Baumgarten C, Rasp G, et al. Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunology 1997;100:23–9
   PubMed Web of Science ®Google Scholar
• Mirone C, Albert F, Tosi A, et al. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study. Clin Exp Allergy 2004;34:1408–14
   PubMed Web of Science ®Google Scholar